Assenagon Asset Management
CDNA icon

Assenagon Asset Management’s CareDx CDNA Stock Holding History

Assenagon Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-65,787
Closed -$2.05M – 1346
2024
Q3 		$2.05M Sell
65,787
-100,518
-60% -$2.5M ﹤0.01% 967
2024
Q2 		$2.58M Sell
166,305
-190,268
-53% -$2.3M 0.01% 824
2024
Q1 		$3.78M Sell
356,573
-219,774
-38% -$2.2M 0.01% 674
2023
Q4 		$6.92M Sell
576,347
-56,729
-9% -$465K 0.02% 547
2023
Q3 		$4.43M Sell
633,076
-502,321
-44% -$4.64M 0.01% 611
2023
Q2 		$9.65M Sell
1,135,397
-28,971
-2% -$242K 0.03% 367
2023
Q1 		$10.6M Buy
1,164,368
+985,010
+549% +$12.6M 0.04% 373
2022
Q4 		$2.05M Buy
179,358
+63,275
+55% +$938K 0.01% 803
2022
Q3 		$1.98M Sell
116,083
-885,405
-88% -$19M 0.01% 719
2022
Q2 		$21.5M Buy
1,001,488
+831,629
+490% +$23.1M 0.08% 216
2022
Q1 		$6.28M Buy
169,859
+8,866
+6% +$346K 0.02% 484
2021
Q4 		$7.32M Buy
+160,993
New +$8.4M 0.02% 411

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Assenagon Asset Management's CDNA Position: Q4 2024 in Review

Assenagon Asset Management sold out of CareDx (CDNA) in Q4 2024, closing a stake of 65,787 shares — an estimated $2.05M sold.

Assenagon Asset Management first reported a position in CDNA in Q4 2021 and held it in 12 quarters. The position peaked at $21.5M in Q2 2022. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

  • Assenagon Asset Management reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 65,787 CareDx shares in Q4 2024, an estimated $2.05M.
  • Assenagon Asset Management first reported a position in CareDx in Q4 2021 and held it in 12 quarters.
  • Assenagon Asset Management's CareDx position peaked at $21.5M in Q2 2022.
  • 210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on Assenagon Asset Management's 13F filing for Q4 2024, filed 14 Jan 2025.